Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website https://www.cardiologyres.org

Review

Volume 15, Number 5, October 2024, pages 340-349


Advances in the Understanding and Treatment of Chronic Chagas Cardiomyopathy

Table

Table 1. Comparison of Chronic Chagas Cardiomyopathy (CCC) and Arrhythmogenic Cardiomyopathy (AC)
 
FeaturesChronic Chagas cardiomyopathy (CCC)Arrhythmogenic cardiomyopathy (AC)
MRI: magnetic resonance imaging.
Risk factorsRural Latin AmericaFamily history (autosomal dominant)
CausesTrypanosoma cruzi infectionGenetic mutations
PathophysiologyDysautonomiaFibrofatty infiltration
Heart failureCommonCommon
Ventricular arrhythmiasCommonCommon
ThromboembolismCommonRare
Ventricular aneurysmsCommon (apical aneurysms)Rare
Right ventricular involvementRareCommon (dilation)
Heart blockCommon (complete)Rare (first-degree)
Chest painCommon (atypical)Rare
Disease-specific findingCommon (megaesophagus, megacolon)Rare
Diagnostic testTransthoracic echocardiogramCardiac MRI
TreatmentBenznidazole, angiotensin-converting enzyme inhibitors, beta-adrenergic blockers, diureticsBeta-adrenergic blockers, angiotensin-converting enzyme inhibitors, antiarrhythmic drugs, implantable cardioverter-defibrillators
ComplicationsHeart failureSudden cardiac death